Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) have been assigned an average rating of “Moderate Buy” from the seven brokerages that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation and six have given a buy recommendation to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $29.50.

Several research analysts have weighed in on ANL shares. Jefferies Financial Group began coverage on shares of Adlai Nortye in a research report on Thursday. They set a “buy” rating and a $31.00 target price on the stock. HC Wainwright reaffirmed a “buy” rating and set a $20.00 price objective on shares of Adlai Nortye in a report on Tuesday. Weiss Ratings reissued a “sell (e+)” rating on shares of Adlai Nortye in a report on Tuesday, July 14th. Loop Capital set a $49.00 price target on Adlai Nortye in a research report on Tuesday. Finally, Oppenheimer initiated coverage on Adlai Nortye in a research report on Thursday, May 28th. They issued an “outperform” rating and a $32.00 price target for the company.

Insider Buying and Selling at Adlai Nortye

In other news, CFO Xiaofeng Ye sold 6,000 shares of the company’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $13.98, for a total transaction of $83,880.00. Following the completion of the transaction, the chief financial officer owned 153,424 shares of the company’s stock, valued at $2,144,867.52. This represents a 3.76% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Institutional Investors Weigh In On Adlai Nortye

Hedge funds have recently modified their holdings of the stock. SmartHarvest Portfolios LLC grew its position in shares of Adlai Nortye by 8.5% during the first quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock worth $113,000 after buying an additional 1,279 shares in the last quarter. Renaissance Technologies LLC acquired a new stake in shares of Adlai Nortye in the 1st quarter valued at about $457,000. Seven Fleet Capital Management LP bought a new position in shares of Adlai Nortye during the second quarter worth about $1,302,000. ADAR1 Capital Management LLC bought a new position in shares of Adlai Nortye during the first quarter worth about $816,000. Finally, Affinity Asset Advisors LLC acquired a new stake in Adlai Nortye during the first quarter valued at approximately $1,140,000. 35.21% of the stock is currently owned by hedge funds and other institutional investors.

Adlai Nortye Stock Performance

NASDAQ:ANL opened at $15.21 on Friday. Adlai Nortye has a 12-month low of $0.88 and a 12-month high of $17.25. The company has a debt-to-equity ratio of 0.04, a current ratio of 9.55 and a quick ratio of 0.65. The stock’s 50 day simple moving average is $13.01 and its 200-day simple moving average is $11.56.

About Adlai Nortye

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.